Lantern Pharma Inc. - Common Stock (NQ:LTRN)

New to The Street Show 775 Premieres Tonight on Bloomberg Television Across the United States, Latin America, MENA and Southeast Asia, Featuring American Fusion, HPB, T-REX Acquisition Corp. and SyncMeOn

October 10, 2026

Fusion energy, solid-state batteries, digital-asset infrastructure and AI-era restaurant procurement lead a four-region broadcast, with commercials from BioVie, Lantern Pharma, Big Sky Industrial and...

InvestorNewsBreaks – Lantern Pharma (NASDAQ: LTRN) to Present at ThinkEquity Conference on Oct. 15

Performance

52-Week Range 85.2% below 52-week high

0.6413

0.6252W Low 4.3452W High

1 Week 19.8% below 1-week high

0.621W Low 0.801W High

Lantern Pharma Inc. - Common Stock (LTRN) traded between $0.62 and $4.34 over the past 52 weeks and last traded at $0.64, 85.2% below its 52-week high. Over the past week it ranged between $0.62 and $0.80.

Past 12 Months

-9.8%

-57.2%

-78.3%

-76.8%

-79.4%

-84.4%

1W -$0.07

1M -$0.86

3M -$2.31

6M -$2.12

YTD -$2.47

1Y -$3.47

LTRN was -84.4% over the past year, -76.8% over six months, -79.4% year to date, -9.8% in the last week.

12 Months vs Market

LTRN

-84.4%

DIA

+11.1%

SPY

+14.2%

QQQ

+17.5%

IWM

+9.3%

Over the past 12 months LTRN returned -84.4% versus DIA (Dow) +11.1%, SPY (S&P 500) +14.2%, QQQ (Nasdaq 100) +17.5% and IWM (Russell 2000) +9.3%.

Volume & Liquidity 0.00× 3-mo avg

Today 103 3-mo avg 185.4K

194.7K

310.8K

185.4K

212.9K

YTD

310.2K

264.2K

LTRN most recently traded 103 shares against a 3-month average daily volume of 185.4K.

More News

October 08, 2026

Lantern Pharma to Present at the ThinkEquity Conference in NYC on October 15th, 2026

October 08, 2026

BioMedNewsBreaks — Lantern Pharma (NASDAQ: LTRN) Receives Taiwan Approvals to Advance Phase 2 HARMONIC(TM) Trial

October 07, 2026

Lantern Pharma Receives Taiwan Approvals to Open Next Stage of Phase 2 HARMONIC™ Trial of LP-300 in Never-Smoker, EGFR-Mutant NSCLC

October 07, 2026

NetworkNewsBreaks – Lantern Pharma (NASDAQ: LTRN) Closes $4 Million Registered Direct Offering

October 01, 2026

Lantern Pharma Inc. Announces Closing of up to $8 Million Registered Direct Offering

September 30, 2026

InvestorNewsBreaks – Lantern Pharma (NASDAQ: LTRN) Announces $4 Million Registered Direct Offering

September 29, 2026

Lantern Pharma Inc. Announces up to $8 Million Registered Direct Offering

September 29, 2026

New to The Street Show 773 Premieres Tonight on Bloomberg Television, Featuring Glint, Sagtec Global, BioVie and SafeSpace Global

September 26, 2026

AINewsBreaks – Lantern Pharma (NASDAQ: LTRN) to Present Open-Medicine AI Growth Plan, Live Platform Demo in Webinar

September 23, 2026

Open-Medicine AI: Lantern Pharma to Present the Agentic AI Drug Development Market, User Needs, Development Roadmap, Platform Economics, and Benchmarks, Today at 12:30 PM ET

September 23, 2026

MissionIRNewsBreaks – Lantern Pharma (NASDAQ: LTRN) Receives USPTO Notice of Allowance for LP-284 Blood Cancer Treatment Patent

September 22, 2026

Lantern Pharma Secures USPTO Notice of Allowance for LP‑284 Treatment Patent in Aggressive B‑Cell Lymphomas

September 22, 2026

New to The Street Broadcasts Tonight at 6:30 PM ET Across the United States, Latin America and MENA, Featuring BioVie, Acurx Pharmaceuticals, Lantern Pharma and SafeSpace Global

September 19, 2026

BioMedNewsBreaks — Lantern Pharma (NASDAQ: LTRN) to Host Webinar on Open-Medicine AI Platform, Business Model and Development Roadmap

September 17, 2026

Lantern Pharma to Present Open-Medicine AI — a Multi-Agentic Platform for End-to-End Therapeutic Development — Business Model, Roadmap, and Value Proposition on September 23

September 17, 2026

New to The Street Show 771 Airs Today on Bloomberg, Featuring Bill Mobley, Panna Sharma, Phillip Toppino and Dr. Kelley Gurley

September 12, 2026

New to The Street Broadcasts at 6:30 PM ET Across Bloomberg U.S., Latin America and MENA, Featuring Lantern Pharma (NASDAQ:LTRN), SafeSpace Global (OTCID:SSGC) and FreeCast (NASDAQ:CAST)

September 05, 2026

New to The Street Broadcasting Today at 6:30 PM EST on Bloomberg Television Across the U.S., Latin America and MENA-Featuring FreeCast (NASDAQ: CAST), Metaterra Holdings (MTHI) and SafeSpace Global (SGCC)

August 29, 2026

NetworkNewsBreaks – Lantern Pharma (NASDAQ: LTRN) Advances AI-Driven Oncology Pipeline, Establishes Open Medicine AI

Lantern Pharma (LTRN) Q2 2026 Earnings Call Transcript ↗

August 21, 2026

Via The Motley Fool

August 14, 2026

Lantern Pharma Reports Second Quarter 2026 Financial Results and Provides Business Update

August 14, 2026

New to The Street Show 766 Broadcasts Tonight at 6:30 PM ET on Bloomberg Television, Featuring BioVie's Bezisterim Parkinson's Disease Clinical Results

August 08, 2026